Emmaus Life Sciences issues convertible note to director for $1M and warrants for services

Emmaus Life Sciences, Inc.

Director loaned $1M via convertible note due demand after 1 yr, 10% interest, convertible at $0.50/share into 2M shares.
Two individuals received warrants for 250K shares each at $0.50/share for consulting services.
Consulting firm received 5-yr warrant for 500K shares at $0.47/share for services.
Total shares underlying instruments represent ~6% of pre-issuance common stock.
Securities issued without registration under Section 4(a)(2) exemption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.